Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression. 

Constellation Pharmaceuticals is focused on rapidly advancing and translating this new and exciting field of science into a new class of breakthrough medicines.